Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07824934
What this trial is testing

HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Sunshine Lake Pharma Co., Ltd. 110
Early research (Phase 1)UnknownNCT05276609
What this trial is testing

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Shanghai Hansoh Biomedical Co., Ltd 177
Testing effectiveness (Phase 2)Ended earlyNCT03573544
What this trial is testing

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
Metastatic Solid TumorsLocally Advanced Solid Tumors
OBI Pharma, Inc 54
Early research (Phase 1)Ended earlyNCT02553499
What this trial is testing

Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)

Who this might be right for
Advanced Solid Tumor
Merck Sharp & Dohme LLC 37
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Early research (Phase 1)Study completedNCT02423057
What this trial is testing

Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsSolid Tumors
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT05032092
What this trial is testing

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

Who this might be right for
Locally Advanced CarcinomaMetastatic Cancer
Medical University of Graz 235
Early research (Phase 1)Ended earlyNCT03387332
What this trial is testing

APG-1252 in Patients With SCLC or Advanced Solid Tumors

Who this might be right for
Small Cell Lung Cancer and Other Solid Tumors
Ascentage Pharma Group Inc. 24
Early research (Phase 1)Looking for participantsNCT06211647
What this trial is testing

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Ruimin Wang 20
Testing effectiveness (Phase 2)Looking for participantsNCT06902389
What this trial is testing

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Eastern Hepatobiliary Surgery Hospital 30
Early research (Phase 1)Study completedNCT00003289
What this trial is testing

UCN-01 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableNo Longer AvailableNCT05511350
What this trial is testing

Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001

Who this might be right for
Solid Tumor Metastatic Cancer Advanced Cancer
I-Mab Biopharma US Limited
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Early research (Phase 1)Study completedNCT00003768
What this trial is testing

Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 25
Early research (Phase 1)Ended earlyNCT03435250
What this trial is testing

Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss

Who this might be right for
Advanced Solid TumorsLymphoma
Institut de Recherches Internationales Servier 123
Testing effectiveness (Phase 2)Looking for participantsNCT06154291
What this trial is testing

FIH XON7 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Cancer
Xenothera SAS 255
Testing effectiveness (Phase 2)Study completedNCT04020185
What this trial is testing

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Who this might be right for
Solid Tumor, Adult
ImmuneSensor Therapeutics Inc. 40
Early research (Phase 1)Looking for participantsNCT05895825
What this trial is testing

EOC237 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., Ltd 48
Testing effectiveness (Phase 2)Ended earlyNCT02472977
What this trial is testing

Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

Who this might be right for
Solid Tumor
Bristol-Myers Squibb 61
Early research (Phase 1)Active Not RecruitingNCT04928508
What this trial is testing

Advanced or Recurrent Solid Tumors Treated With SHetA2

Who this might be right for
Solid Tumor, Adult
University of Oklahoma 50
Next Page